← News
June 2026
Avenio AI Names Dr. Cyrus Ghobadi Board Advisor as Artiko Pharma Adopts Avenio AI for Clinical Protocol Development
Avenio AI has named Dr. Cyrus Ghobadi as a Board Advisor as Artiko Pharma becomes the latest biopharma to adopt Avenio AI's Protocol Hub for clinical protocol development.
Featured in: